Home
Drugs
Bevacizumab
Clinical Trials

Clinical Trials Related to Bevacizumab

Related studies linked through entity extraction aliases.

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Status: COMPLETED
Phase: PHASE2

Breast Cancer Treatment Based on Organ-like Culture

Status: UNKNOWN
Phase: N/A

A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab

Status: COMPLETED
Phase: PHASE1

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)

Status: UNKNOWN
Phase: PHASE3

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Status: UNKNOWN
Phase: PHASE2

Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma

Status: COMPLETED
Phase: PHASE2

Pan Tumor Rollover Study

Status: RECRUITING
Phase: PHASE2

Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

Status: COMPLETED
Phase: N/A

Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

Status: COMPLETED
Phase: PHASE2

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Status: TERMINATED
Phase: PHASE1

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC

Status: RECRUITING
Phase: PHASE2

Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Status: COMPLETED
Phase: PHASE3

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Status: WITHDRAWN
Phase: PHASE2

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Status: WITHDRAWN
Phase: PHASE2

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Status: COMPLETED
Phase: PHASE3